Your session is about to expire
← Back to Search
Liposomal Bupivacaine for Rotator Cuff Repair
Study Summary
This trial is testing whether liposomal bupivacaine is more effective than a catheter in controlling pain and sleep quality after surgery.
- Rotator Cuff Injury
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have had nerve pain or numbness in the limb that will undergo surgery.You have used opioids within 6 weeks before the surgery.You have been diagnosed with long-term pain, fibromyalgia, or other conditions related to the sense of touch.You are currently having a shoulder surgery called outpatient arthroscopic rotator cuff repair.You have planned surgery to fix your biceps tendon or acromioclavicular joint.You have taken gabapentin within 6 weeks prior to the surgery.
- Group 1: Liposomal bupivacaine Interscalene Block
- Group 2: Ropivacaine Interscalene Catheter
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What other experiments have been conducted to explore Exparel's potential use in the medical field?
"Currently, there are 168 running research programs on Exparel with 33 being in the late-stage of testing. Although many clinical trials are taking place near Germantown, Tennessee, a total of 222 sites have been allocated for such studies."
What clinical purpose is Exparel typically employed for?
"Exparel is an effective and safe treatment for various medical conditions such as permphigus, tenosynovitis and anesthesia."
Is the use of Exparel associated with any adverse effects?
"Due to this being a Phase 4 trial with Exparel already approved, its safety rating is highly valued at 3."
Are there any opportunities to join this study?
"Clinicaltrials.gov confirms that the recruitment of participants for this medical trial is still ongoing; it was first announced on December 15th, 2019 and its contents were most recently modified on November 30th 2022."
What is the aggregate quantity of participants enrolled in this experiment?
"Affirmative. Clinicaltrials.gov's data indicates that this trial is actively enrolling participants, having been initially posted on December 15th 2019 and recently updated on November 30th 2022. An aggregate of 80 patients have to be recruited from 1 clinical site."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger